Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.

MLA

Chatham, W.Winn, et al. “Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial.” The Journal of Rheumatology, vol. 39, no. 8, Aug. 2012, pp. 1632–40. EBSCOhost, https://doi.org/10.3899/jrheum.111587.

APA

Chatham, W. W., Wallace, D. J., Stohl, W., Latinis, K. M., Manzi, S., McCune, W. J., Tegzová, D., McKay, J. D., Avila-Armengol, H. E., Utset, T. O., Zhong, Z. J., Hough, D. R., Freimuth, W. W., & Migone, T.-S. (2012). Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial. The Journal of Rheumatology, 39(8), 1632–1640. https://doi.org/10.3899/jrheum.111587

Chicago

Chatham, W Winn, Daniel J Wallace, William Stohl, Kevin M Latinis, Susan Manzi, W Joseph McCune, Dana Tegzová, et al. 2012. “Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial.” The Journal of Rheumatology 39 (8): 1632–40. doi:10.3899/jrheum.111587.